Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Intellia Therapeutics

Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients

Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals discusses a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to...

Impetus Digital

- PMLiVE

Vertex reveals promising data from first CRISPR-treated patients

Investigational gene therapy has potentially curative effect

- PMLiVE

Vertex eyes Duchenne market with Exonics, CRISPR deals

Biotech has gene-editing expertise

- PMLiVE

2019: CRISPR and therapeutic gene editing comes of age

Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?

- PMLiVE

Cutting through the noise: CRISPR

AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery

- PMLiVE

Trial dents confidence in Sangamo’s gene-editing tech

Company proposing switch to next-gen version

- PMLiVE

Horizon taps academic partner to boost gene editing platform

Partners with Rutgers University to license base editing tech

- PMLiVE

Allergan builds on gene editing deal

Firm will co-develop CRISPR candidate for vision-threatening disorder

- PMLiVE

First patient treated with Sangamo’s gene-editing tech

SB-913 uses ZFN technology to insert a corrective gene into the liver cells DNA location

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links